Â¥
6.39
Sep 19
New Key Statistics Module, Z-Score and F-Score
SHSE:603811 Key Ratios
Market Cap ¥ M | 2,091.47 |
Enterprise Value ¥ M | 2,299.09 |
P/E(ttm) | 14.20 |
PE Ratio without NRI | 12.96 |
Forward PE Ratio | -- |
Price/Book | 1.74 |
Price/Sales | 3.00 |
Price/Free Cash Flow | 27.07 |
Price/Owner Earnings | 104.75 |
Payout Ratio % | 0.41 |
Revenue (TTM) ¥ M | 706.00 |
EPS (TTM) ¥ | 0.45 |
Beneish M-Score | -2.23 |
10-y EBITDA Growth Rate % | 12.50 |
5-y EBITDA Growth Rate % | 13.50 |
y-y EBITDA Growth Rate % | -8.00 |
EV-to-EBIT | 12.43 |
EV-to-EBITDA | 12.43 |
PEG | 0.96 |
Shares Outstanding M | 327.30 |
Net Margin (%) | 21.06 |
Operating Margin % | 21.41 |
Pre-tax Margin (%) | 23.70 |
Quick Ratio | 0.70 |
Current Ratio | 0.98 |
ROA % (ttm) | 8.09 |
ROE % (ttm) | 12.64 |
ROIC % (ttm) | 8.75 |
Dividend Yield % | 3.18 |
Altman Z-Score | 3.27 |
SHSE:603811 Number of Guru Trades
SHSE:603811 Volume of Guru Trades
Gurus Latest Trades with SHSE:603811
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603811 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Cheng Yi Pharmaceutical Co Ltd Insider Transactions
No Available Data